A recent study using an injected mouse AML cell line established that non-leukemic cDC1s were solely responsible for acquiring and cross-presenting leukemia-associated-antigen (LAAs) to CD8+ T cells [37]. This evidence concerns the gene CD8A and acute myeloid leukemia.